Alamar Biosciences, Inc. (NASDAQ:ALMR)
| Market Cap | 1.77B+16.0% |
| Revenue (ttm) | 55.46M |
| Net Income | -34.52M |
| EPS | -0.53 |
| Shares Out | 69.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 499,533 |
| Open | 28.05 |
| Previous Close | 27.77 |
| Day's Range | 25.39 - 28.07 |
| 52-Week Range | 18.85 - 39.61 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 33.50(+30.94%) |
| Earnings Date | n/a |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About ALMR
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ALMR stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in ALMR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ALMR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ALMR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
ALMR Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New ALMR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ALMR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ALMR
| ETF | Est. Holding Size |
|---|---|
| ARKGARK Genomic Revolution ETF | $27.80M |
| VTIVanguard Morningstar Total Stock Market ETF | $9.78M |
| IWMiShares Russell 2000 ETF | $9.72M |
| VXFVanguard Extended Market ETF | $4.19M |
| IWOiShares Russell 2000 Growth ETF | $2.41M |
| VTWOVanguard Russell 2000 ETF | $2.33M |
Estimated from each fund’s disclosed top holdings × AUM
ALMR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ALMR’s recent data — informational, not investment advice